VIR 8-K 2026-01-12

Vir Biotechnology, Inc. (VIR) 8-K dated 2026-01-12 — accession 0001628280-26-001768. This URL is the filing, not the VIR hub.

Vir Biotechnology, Inc. (VIR) is a biotechnology company listed on NASDAQ.

Vir Biotechnology, Inc. filed a 8-K on 2026-01-12. Accession 0001628280-26-001768.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.

Not investment advice. The VIR SEC hub lists recent forms. The stock page is the research view.